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sing an animal model system and depletion-rescue
strategies, we have addressed the requirement
and functions of armadillo repeat gene deleted in
velo-cardio-facial syndrome (ARVCF) and p120 catenins in
early vertebrate embryogenesis. We ﬁnd that xARVCF and
Xp120 are essential to development given that depletion of
either results in disrupted gastrulation and axial elongation,
which are speciﬁc phenotypes based on self-rescue analysis
and further criteria. Exogenous xARVCF or Xp120 cross-
rescued depletion of the other, and each depletion was
additionally rescued with (carefully titrated) dominant-
U
 
negative RhoA or dominant-active Rac. Although xARVCF
or Xp120 depletion did not appear to reduce the adhesive
function of C-cadherin in standard cell reaggregation and
additional assays, C-cadherin levels were somewhat reduced
after xARVCF or Xp120 depletion, and rescue analysis
using partial or full-length C-cadherin constructs suggested
contributory effects on altered adhesion and signaling
functions. This work indicates the required functions of
both p120 and ARVCF in vertebrate embryogenesis and
their shared functional interplay with RhoA, Rac, and
cadherin in a developmental context.
 
Introduction
 
The roles of armadillo repeat gene deleted in velo-cardio-facial
syndrome (ARVCF) and p120 catenins in vertebrate devel-
opment have remained open to question even as p120’s
modulation of cadherin-based adhesion and Rho family
(small) GTPases (Anastasiadis et al., 2000; Anastasiadis and
Reynolds, 2001; Grosheva et al., 2001; Noren et al., 2000),
associations with kinesin and microtubules (Chen et al., 2003;
Franz and Ridley, 2004; Yanagisawa et al., 2003), and stabili-
zation of cadherin (Ireton et al., 2002; Davis et al., 2003;
Peifer and Yap, 2003; Xiao et al., 2003) have received attention
in recent cell line studies. In the work presented here, we have
sought to address the requirement of 
 
Xenopus
 
 
 
laevis
 
 xARVCF
and Xp120 in vertebrate embryogenesis, and the functional
interaction of each protein with cadherin and small GTPases.
We find that xARVCF exhibits functional interactions with
small GTPases that are similar to Xp120 and, most notably,
that xARVCF and Xp120 are developmentally required.
The catenin proteins are distinguished by the various
cellular compartments in which they function and the diver-
sity of their protein associations, e.g., those occurring with
the cytoplasmic domain of cadherins (plasma membrane;
Gumbiner, 2000; Peifer and Polakis, 2000), Rho family
GTPases (plasma membrane/cytoplasm; Anastasiadis and
Reynolds, 2001), kinesin and microtubules (Chen et al.,
2003; Yanagisawa et al., 2003; Franz and Ridley, 2004), and
transcription factors (nucleus; Daniel and Reynolds, 1999;
Kim et al., 2002; Bienz and Clevers, 2003). Certainly, the
best characterized catenin family member is 
 
 
 
-catenin
(McCrea et al., 1991), which transduces canonical Wnt
signals in multiple developmental and pathological (cancer)
contexts (Behrens, 2000; Sharpe et al., 2001).
The p120 catenin subfamily is lesser understood and
exhibits functions distinct from 
 
 
 
-catenin (Sirotkin et al.,
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1997; Paulson et al., 1999; Anastasiadis and Reynolds, 2000).
For example, at the plasma membrane, p120 and ARVCF
competitively bind the membrane-proximal (“juxtamem-
brane”) region of cadherin cytoplasmic domains (Mariner et
al., 2000; Paulson et al., 2000), whereas 
 
 
 
-catenin and plako-
globin (
 
 
 
-catenin) competitively bind the membrane-distal
(“catenin-binding”) domain and indirectly associate with the
cortical actin cytoskeleton (Knudsen et al., 1995; Rimm et al.,
1995). Recent papers further demonstrate the association of
p120 with kinesin and microtubules (Chen et al., 2003; Franz
and Ridley, 2004) and with the POZ/zinc finger transcription
factor Kaiso (Daniel and Reynolds, 1999; Kim et al., 2002;
Yanagisawa et al., 2003), whereas nuclear partners of ARVCF
and 
 
 
 
-catenin remain to be identified.
Arising from effects on cadherin stability and clustering
(Ireton et al., 2002; Davis et al., 2003; Peifer and Yap, 2003;
Xiao et al., 2003) or on small GTPases and the cell cytoskel-
eton, p120 is thought to positively or negatively regulate cell
adhesion and motility (Brieher et al., 1996; Yap et al., 1998;
Aono et al., 1999; Ohkubo and Ozawa, 1999; Paulson et al.,
2000; Thoreson et al., 2000). For example, depending on
p120’s intracellular localization to cell junctions or the cyto-
plasm and free cell edges, p120 may promote cell adhesion
versus motility via activation of Rac and Cdc42 and inhibi-
tion of RhoA (Anastasiadis et al., 2000; Anastasiadis and
Reynolds, 2000, 2001; Noren et al., 2000; Grosheva et al.,
2001; Magie et al., 2002). In this manner, p120 has been
likened to a molecular switch contributing to both cell adhe-
sion and motility.
The junctional organization and adhesive activity of cell–
cell contacts containing cadherins is further known to be re-
sponsive to Rho family GTPases (Braga, 2000; Fukata and
Kaibuchi, 2001), which in turn are responsive to the levels
and adhesive activity of cadherins (Kim et al., 2000; Naka-
gawa et al., 2001; Noren et al., 2001; Goodwin et al., 2003).
Such functional interdependencies are believed to promote
vertebrate gastrulation (Gumbiner, 2000; Tepass et al.,
2000), wound healing, or pathologies, including a variety of
human carcinomas (Behrens, 1999; Nollet et al., 1999;
Anastasiadis and Reynolds, 2000; Van Aken et al., 2001;
Thoreson and Reynolds, 2002).
At the biochemical level, the activation of Rac and Cdc42
by p120 appears to be mediated via its direct association
with the guanine nucleotide exchange factor (GEF) Vav2
(Noren et al., 2000), which promotes the residence of GTP
(as opposed to GDP) within the nucleotide binding pocket
of Rho family GTPases such as Rac. In contrast, inhibition
of RhoA is likely to occur as a consequence of direct p120–
RhoA complex formation in which p120 functions as a gua-
nine nucleotide dissociation inhibitor (GDI; Anastasiadis et
al., 2000; Magie et al., 2002), favoring the residence of GDP
within RhoA’s nucleotide binding pocket.
Because effectors of Rho family GTPases are numerous
(Bishop and Hall, 2000), various outcomes likely follow p120
(or ARVCF) activation of Rac or Cdc42 or inhibition of
RhoA. In addition to effects on the actin cell cytoskeleton,
Rho family GTPases have roles in other essential biological
processes, e.g., in transducing developmental signals within
noncanonical Wnt pathways (Myers et al., 2002). Thus, al-
though modulation of the actin cytoskeleton comprises a sig-
nificant aspect of Rho family functions, each GTPase acts in
additional cellular and developmental capacities.
Given cell line studies indicating that p120 modulates cad-
herin function and Rho family GTPases, we tested if p120
and/or ARVCF are required in early vertebrate development.
Using early 
 
X. laevis
 
 embryos, we further assessed if ARVCF
regulates Rac, Cdc42, and RhoA in a manner similar to that
proposed for p120. Our work, conducted in 
 
X. laevis
 
 and using
a depletion-rescue strategy in conjunction with biochemical
and cell biological analyses, indicates that Xp120 and xARVCF
are each developmentally essential, and that these two catenins
share related functions in early embryogenesis via the stabiliza-
tion of cadherin, activation of Rac, and inhibition of RhoA.
 
Results
 
xARVCF or Xp120 proteins are specifically depleted 
upon treatment with morpholino oligonucleotides (MOs)
 
To assess the requirement of xARVCF and Xp120 in early
vertebrate development, we used an established MO ap-
Figure 1. Morpholino-directed depletion of xARVCF or Xp120. 
xARVCF and Xp120 protein from total embryo extracts isolated at 
the indicated developmental stages were detected via SDS-PAGE/
Western blotting using anti-xARVCF or anti-Xp120 polyclonal anti-
bodies. Embryos at the 1-cell stage were injected with a combination 
of either xARVCF morpholinos (5 ng each of xARVCF MO I and MO II, 
total delivery) or of Xp120 morpholinos (40 ng each of Xp120 MO I 
and MO II, total delivery), while the standard control morpholino 
was injected at matched doses. Protein loads were assessed by 
Western blotting samples for actin. The anti-Xp120 antibody recog-
nizes three major Xp120 isoforms. Developmental stages presented 
include 6 or 7 (blastula, before zygotic transcription/mid-blastula 
transition), 11 or 12 (late gastrula), and 20 (early tailbud). When 
comparing experimental samples with their stage-matched standard 
control, depletion efficiencies ranged from 20–90% depending on 
factors including embryo batch variation, the morpholinos used, 
and morpholino dose. xARVCF displayed an SDS-PAGE mobility of 
 100 kD, whereas the Xp120 isoforms migrated between 92–98 kD; 
p120’s lowermost band/isoform may arise as a consequence of protein 
degradation given its appearance in some but not all experiments. 
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proach to deplete (“knockdown”) endogenous xARVCF or
Xp120 in 
 
X. laevis
 
 (Heasman et al., 2000). MOs were
designed to block the protein translation of xARVCF
(xARVCF-MOI and -MOII) or Xp120 (Xp120-MOI and
-MOII; see Materials and methods). In brief, oligonucle-
otide sequences were selected to complement the start ATG
and adjoining proximal 5
 
 
 
 UTR of the mRNA, thereby dis-
rupting ribosome binding and progress along the transcript.
For initial morpholino characterization, injections of 10–80
ng were made into the animal region of single-cell embryos,
which were permitted to develop through gastrula, neurula,
and early tailbud stages. To test MO effectiveness, extracts
were isolated and xARVCF or Xp120 protein levels were re-
solved via SDS-PAGE/Western blotting using specific rab-
bit polyclonal sera or affinity-purified antibodies directed
against xARVCF (Paulson et al., 2000) or Xp120 (see Mate-
rials and methods). In accordance with embryo batch vari-
ance, the morpholino selected, its dose, and whether used
singly or in combination, depletions ranged from 20% to
 
 
 
90% (Fig. 1). Injection of an established standard control
morpholino at comparable doses did not result in xARVCF
or Xp120 depletion, suggesting specificity of our xARVCF
or Xp120 MOs. xARVCF-MOII and Xp120-MOI exhib-
ited the most favorable respective depletions of xARVCF
or Xp120 and were used in subsequent experimentation.
In accordance with the morpholino approach in general,
xARVCF or Xp120 depletions were effective but not abso-
lute (not equivalent to a genetic null), a point that will per-
tain to the later interpretation of our results.
 
C-Cadherin levels are reduced after xARVCF 
or Xp120 depletion
 
Given that p120 was recently shown to enhance cadherin
stability in mammalian cell lines (Ireton et al., 2002; Davis
et al., 2003; Peifer and Yap, 2003; Xiao et al., 2003), we
wished to test in vertebrate embryos if xARVCF or Xp120
depletion results in reduced levels of C-cadherin, the pre-
dominant early embryonic cadherin of 
 
X. laevis
 
 (Choi et al.,
1990; Angres et al., 1991). Indeed, total levels of C-cadherin
were slightly to moderately reduced (10–50%) after MO in-
jection at the 1-cell stage (Fig. 2). Injection at the 1-cell
stage facilitated visualization of resulting decreases in protein
levels, whereas injections at the 4-cell stage facilitated phe-
notypic depletion-rescue analyses (see Results sections using
depletion-rescue approaches). In summary, we find that in
addition to Xp120 catenin, xARVCF contributes to cad-
herin stability during vertebrate embryogenesis.
 
xARVCF and Xp120 are each required in early 
 
X. laevis 
 
development
 
To assess the developmental outcome of reduced xARVCF
or Xp120 levels, MOs were injected into the animal pole of
one or two dorsal cells within 4-cell embryos (Fig. 3 and Ta-
bles I and II). Although introduced at early (cleavage) stages
of embryogenesis, when maternal mRNAs predominate,
morpholinos continue to function after the mid-blastula
transition (stage 8) when zygotic transcription/translation is
initiated in 
 
X. laevis
 
. At doses ranging from 10–40 ng, we
observed gastrulation defects whose penetrance varied from
20–90% of embryos, as a function of the morpholino, its
dose, and the batch of embryos used. To control for the ef-
fect of MO delivery (injection) and its presence during em-
bryogenesis, similar or greater doses of an established “stan-
dard control” morpholino were introduced. As anticipated,
injection of the standard control morpholino resulted in
considerably lesser effects relative to experimental morpholi-
nos, and in many cases were in keeping with background
levels observed in water-injected or uninjected embryos
(Figs. 3 and 4; and Tables I and II).
In contrast, injection of xARVCF-MOII or Xp120-MOI
at doses of 
 
 
 
10 ng produced significantly larger fractions of
embryos displaying aberrant gastrulation. Gross morphologi-
cal examination of injected embryos indicated normal devel-
opment at early cleavage and blastula stages, whereas gastrula
stage embryos exhibited blastopore closure defects in associa-
tion with subtle extents of extruded endoderm, phenotypes
characteristic of aberrant convergent extension, and meso-
derm involution (Fig. 3 and Tables I and II). Most depleted
embryos retained the capacity to proceed through gastrula-
tion, early neurogenesis, and neural fold closure, whereupon
effects included reduced extension of the dorsal axis made ap-
parent in a bowed appearance at late neurula and tailbud
stages, effects again typical of aberrant convergent-extension
(Fig. 3 and Tables I and II). When compared within the
same experiment, embryos depleted for both xARVCF and
Xp120 displayed more severe gastrulation phenotypes than
single depletions and did not progress into neurulation stages
(unpublished data). Likewise, greater outward effects fol-
Figure 2. xARVCF or Xp120 depletion 
results in reduced C-cadherin levels. X. 
laevis C-cadherin protein in total embryo 
extracts was detected using anti–C-cad-
herin polyclonal antibody. Embryos were 
injected at the 1-cell stage with 20 ng 
each of xARVCF morpholino, Xp120 
morpholino, or standard control mor-
pholino and harvested at developmental 
stages 11 (gastrula) or 20 (early tailbud). 
Protein loads were assessed by Western 
blotting samples for actin. C-Cadherin 
reduction after embryonic depletion of 
xARVCF or Xp120 ranged from 10–50% 
depending on factors including embryo 
batch variation, the morpholinos used, 
and morpholino dose. 
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lowed dorsal versus ventral depletions, which is consistent
with the more graphic morphogenic requirements of dorsal
tissues. These findings indicate that xARVCF and Xp120 are
each required in early vertebrate development.
 
Specificity of the xARVCF or Xp120 depletion 
phenotype indicated via self-rescue
 
To assess if the xARVCF or Xp120 depletion phenotype is
specific, we tested the respective capacity of exogenous
xARVCF or Xp120 to rescue their depletion in vivo. In-
deed, morpholino-directed depletion of xARVCF was res-
cued upon expression of exogenous xARVCF (injection of
in vitro transcribed mRNA), and likewise the depletion of
Xp120 rescued upon expression of exogenous Xp120 (Fig.
3 and Tables I and II). Importantly, we used minimal res-
cuing doses of xARVCF or Xp120 mRNAs that had been
titrated to exhibit no or very minimal effects when injected
alone (Tables I and II). This process was required given
that p120 perturbs development when expressed at higher
doses (Geis et al., 1998; Paulson et al., 1999). Because
nearly complete rescues followed minimal-dose injections
of xARVCF or Xp120 mRNA, our depletion phenotypes
Figure 3. xARVCF and Xp120 are essential to embryonic devel-
opment. Embryos were depleted for xARVCF or Xp120 (20 ng 
morpholino injected into one dorsal cell at the 4-cell stage) or 
injected with 20 ng of standard control morpholino. Substantial 
rescues were effected via coinjection of morpholino with xARVCF 
or Xp120 in vitro transcribed mRNA (0.01 ng), indicating specificity 
of the depletion phenotypes. Embryos were scored at stage 12 
(gastrula) for defects (histogram), which included partial/improper 
closure of the blastopore. As depicted, depleted embryos at later 
stages (tailbud and tadpole) displayed a bowed appearance charac-
teristic of reduced dorso-axial mesoderm elongation, which was 
likewise rescuable to the standard control (normal embryo) phenotype. 
(A) xARVCF depletions and rescue upon coinjection of xARVCF 
mRNA. (B) Xp120 depletions and rescue upon coinjection of Xp120 
mRNA. See also combined depletion/rescue data presented in 
Tables I and II.
Figure 4. Xp120 partially rescues depletion of xARVCF, and xARVCF 
largely rescues codepletion of xARVCF and Xp120. (A) Gastrulation 
defects in embryos depleted for xARVCF (20 ng morpholino injected 
into one dorsal blastomere at the 4-cell stage) were largely rescued 
upon coinjection of xARVCF in vitro transcribed mRNA (0.01 ng, 
positive control for rescue) as well as substantially cross-rescued 
upon coinjection of Xp120 mRNA (0.01 ng). (B) Gastrulation defects 
in embryos codepleted for xARVCF and Xp120 (20 ng of respective 
morpholino coinjected into one dorsal blastomere at the 4-cell stage) 
were largely rescued upon coinjection of xARVCF and Xp120 in vitro 
transcribed mRNAs (0.02 ng of respective mRNA, positive control 
for codepletion rescue) or upon coinjection of xARVCF mRNA alone 
(0.02 ng). 
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likely resulted from the targeted reduction of xARVCF
or Xp120. Furthermore, because our rescuing constructs
lack any 5
 
 
 
 UTR sequence, they did not complement
(xARVCF-MOI and Xp120-MOI) or only partially com-
plemented the morpholinos used (xARVCF-MOII and
Xp120-MOII). Thus, the rescues are unlikely to have been
successful as a consequence of morpholino sequestration,
again suggesting the specificity of our observed phenotypes
(see the following paragraph).
 
Depletion of xARVCF is partially rescued by exogenous 
Xp120 and vice versa
 
Because xARVCF and Xp120 are structurally similar mem-
bers of the p120 sub-class of catenins, we assessed if deple-
tion of one could be functionally compensated by increasing
the level of the other. As in the aforementioned experiments,
we assayed a range of Xp120 or xARVCF mRNA concentra-
tions to optimize their potential effectiveness. We found
that Xp120 largely cross-rescues depletion of xARVCF, and
conversely, that xARVCF largely rescues codepletion of
xARVCF and Xp120 (Fig. 4). Because the Xp120 and
xARVCF mRNAs lack sequence complementarity in the re-
gions targeted by their respective morpholinos, observed
phenotypes likely resulted from selective xARVCF or Xp120
depletion (Figs. 1 and 2). However, complicating matters
somewhat is that depletion of one catenin produced slight
but measurable decreases of the other (not depicted), per-
haps as an indirect consequence of lowered cadherin stability
(Fig. 2) or an unknown indirect effect. In any case, given the
cross-rescues, we propose that xARVCF and Xp120 share
significant functional overlap in early vertebrate develop-
ment (see following Results sections).
 
C-Cadherin partially rescues depletion of xARVCF 
or Xp120
 
Because the depletion of xARVCF or Xp120 resulted in
slightly reduced C-cadherin levels (Figs. 1 and 2), we tested
if exogenous C-cadherin would rescue embryogenesis in de-
pleted embryos. We found that a carefully titrated level of
C-cadherin mRNA rescued to a significant extent pheno-
 
Table I.  
 
Rescue of gastrulation defects after xARVCF depletion
Morpholino oligo 
 
 
 
 mRNA injected Normal Gast. defect Embryos Expt.
 
%%
 
xARVCF morpholino 31 69 233 7
xARVCF morpholino 
 
  
 
xARVCF mRNA 84 16 128 3
xARVCF morpholino 
 
 
 
 DN-RhoA mRNA 85 15 115 3
xARVCF morpholino 
 
 
 
 DA-Rac mRNA 84 16 167 2
xARVCF morpholino 
 
 
 
 C-cadherin mRNA 82 18 60 2
xARVCF mRNA 86 14 66 3
DN-RhoA mRNA 84 16 89 3
DA-Rac mRNA 85 15 60 2
C-Cadherin mRNA 86 14 59 2
Standard control morpholino 94 6 195 7
Uninjected 97 3 272 7
 
Xenopus
 
 embryos were injected with xARVCF morpholino (20 ng, one cell at the 4-cell stage), and rescues were undertaken with xARVCF in vitro transcribed
mRNA (0.02 ng) or RhoA or Rac mRNA (0.5 pg). To avoid overexpression phenotypes, the injection doses of all rescuing constructs were carefully titrated
to produce minimal effects when injected alone. Embryos (
 
n
 
) were scored at gastrula stages for defects. This table shows the combined data of multiple
experiments.
Table II.  
 
Rescue of gastrulation defects after Xp120 depletion
Morpholino oligo 
 
 
 
 mRNA injected Normal Gast. defect Embryos Expt.
 
%%
 
Xp120 morpholino 39 61 240 8
Xp120 morpholino 
 
 
 
 Xp120 mRNA 83 17 127 2
Xp120 morpholino 
 
 
 
 DN-RhoA mRNA 82 18 176 4
Xp120 morpholino 
 
 
 
 DA-Rac mRNA 84 16 89 2
Xp120 morpholino 
 
 
 
 C-cadherin mRNA 81 19 155 3
Xp120 mRNA 86 16 56 2
DN-RhoA mRNA 90 10 126 4
DA-Rac mRNA 83 17 63 2
C-Cadherin mRNA 86 14 109 3
Standard control morpholino 91 9 207 8
Uninjected 98 2 166 8
 
Xenopus
 
 embryos were injected with Xp120 morpholino (20 ng, one cell at the 4-cell stage), and rescues were undertaken with Xp120 in vitro transcribed
mRNA (0.02 ng) or RhoA or Rac mRNA (0.5 pg). To avoid overexpression phenotypes, the injection doses of all rescuing constructs were carefully titrated
to produce minimal effects when injected alone. Embryos (
 
n
 
) were scored at gastrula stages for defects. This table shows the combined data of multiple
experiments. 
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types arising from xARVCF or Xp120 depletion (Fig. 5),
suggesting that reduced C-cadherin levels are contributory
to our observed developmental phenotypes.
 
C-Cadherin adhesive function is not graphically altered 
after xARVCF or Xp120 depletion
 
Given that C-cadherin levels were reduced in embryos de-
pleted for xARVCF or Xp120 (Fig. 2), and given the capacity
of exogenous C-cadherin to rescue such embryos (Fig. 5), we
tested if xARVCF or Xp120 depletion altered C-cadherin–
mediated adhesion using a well established blastomere re-
aggregation assay (see Materials and methods). Contrary to
our initial expectations, no observable effects on cell reaggre-
gation followed xARVCF or Xp120 depletion (Fig. S1, avail-
able at http://www/jcb.org/cgi/content/full/jcb.200307109/
DC1). Using three additional assays, we likewise did not ob-
serve altered tissue integrity or aberrant cell–cell contacts in
xARVCF, Xp120, or doubly-depleted embryos or animal
caps (Figs. S2–S4, available at http://www/jcb.org/cgi/
content/full/jcb.200307109/DC1).
However, one functional strategy did suggest effects on
C-cadherin adhesive function resulting from Xp120 depletion.
A carefully titrated level of C-cadherin ectodomain (EC)
construct partially rescued Xp120 depletion phenotypes
(construct included the C-cadherin transmembrane domain
but not cytoplasmic sequence; Fig. S5, available at http://
www/jcb.org/cgi/content/full/jcb.200307109/DC1). C-Cad-
herin’s juxtamembrane (JMR) domain also displayed par-
tial rescuing activity in isolation (tethered to the inner
plasma membrane via an engineered myristylation sequence),
but to a lesser extent than the EC construct or native (full-
length) C-cadherin (Fig. S5 and Fig. 5). Given that C-cad-
herin’s EC reproducibly exhibited rescuing activity, we con-
jecture that the adhesive function of C-cadherin is reduced
after Xp120 (or xARVCF) depletion, but to a subtle extent
that is not readily detectable using accepted direct or indi-
rect assays of cadherin function (Figs. S2–S4).
 
xARVCF or Xp120 depletion inhibits 
morphogenic movements
 
To test depletion effects on cadherin-dependent morpho-
genic movements (convergent-extension), we used an ex
vivo explant assay in which activin-induced naive ectoderm
(animal caps) reflect aspects of the more elaborate in vivo
process, wherein dorsal mesoderm cells polarize and con-
verge toward the dorsal midline during gastrulation to drive
mesoderm involution as well as subsequent embryo elonga-
tion along the anterior–posterior axis.
Naive ectoderm (animal caps) were excised from late
blastula embryos (stage 9), and convergent-extension re-
sponses were scored after the addition (versus not) of activin,
a member of the TGF-
 
 
 
 family of morphogenic factors.
Consistent with our embryonic phenotypes (Fig. 3 and Ta-
bles I and II), animal caps depleted for xARVCF or Xp120
exhibited a significantly reduced ability to converge and ex-
tend (Fig. 6), suggesting that xARVCF and Xp120 contrib-
ute to the directed interdigitation of cells in vivo.
 
Depletion of xARVCF or Xp120 is rescued by dominant-
negative (DN)–RhoA or dominant-active (DA)–Rac
 
Given mammalian cell line studies indicating that p120 in-
hibits RhoA and activates Rac and Cdc42 (Introduction),
we asked if this functionality is evident in vertebrate em-
bryogenesis. Upon the coinjection of either DN-Rho or
Figure 5. C-Cadherin rescues xARVCF 
or Xp120 depletion. Embryos were 
injected with 20 ng of standard control 
morpholino or depleted for xARVCF or 
Xp120 (20 ng of respective morpholino 
injected into one dorsal cell at the 4-cell 
stage). Rescues were effected by coin-
jection of xARVCF or Xp120 morpholino 
with C-cadherin in vitro transcribed 
mRNA (2 ng) and scored at stage 12 
(gastrula) for defects including partial/
improper closure of the blastopore. 
Resulting gastrulation phenotypes are 
shown in A with percentages presented 
in B. Depletion phenotypes and C-cad-
herin rescues were apparent at both 
gastrula and later developmental stages 
(tailbud and tadpole). 
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DA-Rac (whose levels had been titrated to generate no or lit-
tle effect when injected in isolation; Tables I and II), we ob-
served the nearly complete rescue of embryos depleted of
xARVCF or Xp120 (Figs. 7 and 8). In contrast, neither DA-
Cdc42, DN-Cdc42, DA-Rho, or DN-Rac effected rescue of
xARVCF- or Xp120-depleted embryos (Fig. S6, available at
http://www/jcb.org/cgi/content/full/jcb.200307109/DC1).
Thus, we demonstrate that xARVCF and Xp120 are func-
tionally linked with RhoA and Rac in a vertebrate develop-
mental system; in contrast to cell line work (Noren et al.,
2000), a linkage with Cdc42 was not made evident.
 
xARVCF produces a dendritic phenotype when expressed 
in NIH-3T3 cells and associates with Vav2 and RhoA
 
To further test the capacity of xARVCF to functionally in-
teract with RhoA and Rac, we turned to phenotypic assays
using mammalian cell lines and coimmunoprecipitation
tests from 
 
X. laevis 
 
extracts. When transiently overexpressed
in NIH-3T3 cells, xARVCF produced the same dendritic
phenotype known to arise after overexpression of p120, a
phenotype that further bore similarity in being rescuable
upon the coexpression of DA-RhoA (Fig. 9; Anastasiadis et
al., 2000).
The shared ARVCF, p120, and rescue phenotypes exhib-
ited in both in vitro and in vivo contexts suggest that
xARVCF and Xp120 have underlying protein–protein inter-
actions in common. As previously demonstrated for p120 in
mammalian cell line and purified in vitro systems (Introduc-
tion), we therefore tested if xARVCF binds to Vav2 (an acti-
vator of Rac and other Rho family GTPases) and to RhoA
(p120 is believed to act as a Rho GDI). Indeed, after their
coexpression in NIH-3T3 cells, we resolved xARVCF’s spe-
cific coimmunoprecipitation with Vav2 (Fig. S7, available
at http://www/jcb.org/cgi/content/full/jcb.200307109/DC1).
From 
 
X. laevis 
 
embryo extracts, we likewise resolved xARVCF’s
specific coimmunoprecipitation with DN-RhoA (6
 
 
 
 Myc
epitope tagged) as well as Xp120’s expected coassociation
with DN-RhoA (Fig. S8, available at http://www/jcb.org/
cgi/content/full/jcb.200307109/DC1). DN-RhoA was used
for these coimmunoprecipitations tests because it largely ex-
ists in the GDP-bound state to which Rho GDIs preferen-
tially associate. Thus, in vertebrate embryogenesis, xARVCF
and Xp120 are each essential and likely to be direct GDIs of
RhoA as well as activators of Rac in complex with the activa-
tor/GEF protein Vav2.
 
Discussion
 
In this work, we find that the structurally homologous
xARVCF and Xp120 catenins share down-stream effector
pathways based on multiple criteria. First, the targeted (mor-
pholino-directed) depletion of either protein in early 
 
X. lae-
vis
 
 embryos generates similar gross morphological pheno-
types, which indicate the requirement of both xARVCF and
Xp120 in vertebrate development. Second, the depletion of
xARVCF or Xp120 is rescuable via the (properly titrated)
exogenous expression of the other catenin, suggesting
overlapping embryonic functions. Third, the depletion of
xARVCF or Xp120 is rescued to significant degrees upon
(properly titrated) exogenous expression of DN-RhoA, DA-
Rac, or C-cadherin, indicating that Rho family GTPases
and cadherin are mediators of both catenins’ functions in
vertebrate embryogenesis. Fourth, the overexpression of
xARVCF in NIH-3T3 cells produced a phenotype similar to
that observed after p120 overexpression, which was further
alike in being rescuable via DA-RhoA coexpression. Finally,
on the biochemical level, we determined that both xARVCF
and Xp120 coprecipitate with RhoA and that xARVCF co-
precipitates with Vav2, which is a Rho family (Rac) GEF
known to bind p120.
Figure 6. xARVCF and/or Xp120 depletion inhibits convergent-extension of naive ectoderm explants. Embryos were injected with standard 
control morpholino or depleted for xARVCF and/or Xp120 (40 ng of respective morpholino injected into animal hemisphere of each cell of 
2-cell embryos). Animal caps were subsequently isolated from stage 8 (blastula) embryos and incubated in the absence or presence of 20 ng/ml 
human activin A. Elongations were scored on a scale of 0–3, respectively reflecting no, slight, moderate, or full extension relative to activin-treated 
caps injected with the standard control morpholino. Total scores were calculated by multiplying the number of caps receiving a particular 
score by that score, and then summing such products across the four score categories. Depletion of xARVCF and/or Xp120 significantly 
reduced the fraction of caps displaying strong elongations. The chart displays aggregate data from two experiments. The asterisk notes that 
the score distribution of the xARVCF   Xp120 double depletion resembles that of xARVCF or Xp120 single depletions, although fewer total 
caps were examined. 
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Prior studies conducted in mammalian cell lines are con-
sistent with a number of these observations (Anastasiadis et
al., 2000; Noren et al., 2000; Anastasiadis and Reynolds,
2001; Grosheva et al., 2001). Interestingly, the neural cell-
specific 
 
 
 
-catenin was also shown to functionally interact
with RhoA (and cortactin), suggesting that multiple mem-
bers of the p120 subfamily may interact with small GTPases
(Martinez et al., 2003). Thus, in both embryological and
cell line contexts, it appears that ARVCF and p120 inhibit
RhoA while activating Rac. A question that arises is if
xARVCF and Xp120 are redundant with respect to func-
tional interactions with Rho family GTPases or other molec-
ular pathways. Certainly, each catenin’s presence is required
in the embryo given that xARVCF or Xp120 depletion
results in perturbed gastrulation. Furthermore, because
xARVCF or Xp120 depletion does not result in the com-
plete absence of either protein product, the nondepleted
(surviving) fraction of each catenin is likely to continue exe-
Figure 7. DN-RhoA rescues xARVCF or Xp120 depletion. Embryos 
were injected with standard control morpholino or depleted for 
xARVCF or Xp120 (20 ng respective morpholino injected into one 
dorsal cell of 4-cell embryos). Rescues were effected by coinjection 
of xARVCF or Xp120 morpholino with xARVCF or Xp120 in vitro 
transcribed mRNA (0.02 ng, self-rescue positive control) or with 
DN-RhoA mRNA (0.5 pg) and scored at gastrula stages 10–12. (A) 
DN-RhoA rescues xARVCF depletion to almost self-rescue and 
standard control injection levels. (B) DN-RhoA rescues Xp120 
depletion to self-rescue and standard control injection levels. As 
depicted, depletion phenotypes and DN-RhoA rescues were apparent 
at both gastrula and later developmental stages (tailbud and tadpole). 
See also aggregate depletion/rescue data presented in Tables I and II.
Figure 8. DA-Rac rescues xARVCF or Xp120 depletion. Embryos 
were injected with standard control morpholino or depleted for 
xARVCF or Xp120 (20 ng respective morpholino injected into one 
dorsal cell of 4-cell embryos). Rescues were effected by coinjection 
of xARVCF or Xp120 morpholino with 0.5 pg DA-Rac and scored at 
gastrula stages 10–12. DA-Rac rescues xARVCF (A) or Xp120 (B) 
depleted embryos to substantial extents relative to standard control 
injections. As depicted, depletion phenotypes and DA-Rac rescues 
were apparent at both gastrula and later developmental stages 
(tailbud and tadpole). See also combined depletion/rescue data 
presented in Tables I and II. 
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cuting a subset of xARVCF- versus Xp120-specific func-
tions, which will escape phenotypic detection. Thus, we pro-
pose that xARVCF or Xp120 have required and overlapping
relationships with Rho family GTPases and cadherins dur-
ing early 
 
X. laevis
 
 embryogenesis, while additional functions
unique to one or the other catenin exist and likely play im-
portant biological roles.
In the mouse, ARVCF or p120 knockouts have not yet
been published, although work in progress indicates that the
functional inactivation of p120 is embryonic lethal (Rey-
nolds, A., L. Elia, and L. Reichardt, personal communica-
tions). However, in 
 
Drosophila melanogaster
 
 or 
 
Caenorhabdi-
tis elegans, 
 
deletion or depletion (siRNA) of the single p120/
ARVCF-like gene product surprisingly results in animals of
wild-type appearance and fertility (Myster et al., 2003; Pet-
titt et al., 2003). However, genetic backgrounds sensitized
for cadherin/junctional function reveal significant genetic
interactions when crossed with p120-deficient animals, indi-
cating their coupled contribution to invertebrate develop-
ment. Furthermore, flies deficient in RhoA (
 
D. melanogaster
 
Rho1) display functional interactions with p120 (siRNA de-
pletion), while biochemical tests demonstrated RhoA’s di-
rect physical association with p120 and 
 
 
 
-catenin (Magie et
al., 2002). Thus, although both invertebrate and vertebrate
p120/ARVCF appear to interact with Rho family GTPases
and with cadherins, the respective impact of reducing p120/
ARVCF function differs with vertebrates exhibiting the
greater functional dependence.
In our work, effects arising from the morpholino-directed
depletion of xARVCF or Xp120 were largely rescued by ex-
ogenous introduction of titrated levels of DN-RhoA, DA-
Rac, or C-cadherin. Each of those embryonic rescues can be
accounted for if endogenous xARVCF/Xp120 inhibits
RhoA, activates Rac, and contributes to the function/stabili-
zation of cadherins. We are uncertain as to why human
ARVCF overexpression was earlier found to lack activity in
producing a dendritic phenotype in mammalian cells (Anas-
tasiadis et al., 2000), but the distinction may conceivably be
due to a difference in construct expression levels or an iso-
form or mutational difference (indeed, upon sequencing the
human ARVCF construct used in the other work, we de-
tected a P
 
→
 
L transition at amino acid 222). In any case,
consistent with xARVCF acting as an inhibitor/GDI of
RhoA in vivo, we find that xARVCF (and Xp120) coprecip-
itates with DN-RhoA from 
 
X. laevis 
 
extracts and that DA-
RhoA rescues the dendritic phenotype of NIH-3T3 cells
overexpressing xARVCF. Thus, we expect that xARVCF is
an inhibitor/GDI of RhoA as demonstrated for p120 (Anas-
tasiadis et al., 2000; Magie et al., 2002). In further likeness
to p120 (Noren et al., 2000), we find that xARVCF
biochemically associates with Vav2, an activator/GEF of
Rac, and more impressively that the embryonic depletion
of xARVCF (or Xp120) is rescued by DA-Rac. Finally,
xARVCF or Xp120 depletion results in reduced C-cadherin
levels, which when exogenously increased, rescues normal
embryogenesis. As indicated in recent papers (Fujita et al.,
2002; Ireton et al., 2002; Davis et al., 2003; Xiao et al.,
2003), we expect that the mechanism by which xARVCF
and Xp120 protein levels are coupled to that of C-cadherin
involves the catenins’ modulation of the complex’s meta-
bolic stability.
Given that DN-Rho, DA-Rac, and C-cadherin rescue
xARVCF or Xp120 depletion in vivo, all five proteins likely
have coupled functions in embryogenesis. For example, exog-
enous DA-Rac or DN-Rho have the capacity to compensate
for reduced C-cadherin protein levels after xARVCF or
Xp120 depletion, perhaps by enhancing the remaining cad-
herin adhesive (extracellular) and/or signaling (intracellular)
function. As alluded to previously, a further possibility is that
rescues mediated by DN-Rho and DA-Rac occur via effects
on cadherin metabolic stability by way of modulating cad-
herin endocytosis/destruction or delivery to the plasma mem-
brane (Akhtar and Hotchin, 2001; Fujita et al., 2002; Le et
al., 2002; Paterson et al., 2003; Yanagisawa et al., 2003).
Developmental events such as gastrulation require cad-
herins to be organized in a fashion that is responsive to de-
velopmental cues (Gumbiner, 1996; Keller et al., 2000; Te-
pass et al., 2000). Given the partial reductions in C-cadherin
levels observed after xARVCF or xp120 depletion, we were
surprised that few effects were evident using various cell–cell
adhesion or tissue integrity assays. One possibility is that
C-cadherin extracellular adhesive activity is indeed reduced but
Figure 9. Overexpression of xARVCF 
produces a dendritic phenotype in NIH-
3T3 cells that is rescuable by DA-RhoA. 
NIH-3T3 cells were transfected with 
xARVCF, together with pcDNA3 (control 
vector) or pcDNA3-RhoA-(V12)-Myc 
(DA-RhoA). After 24 h, cells were fixed 
in PFA and double labeled for immuno-
fluorescent microscopy using anti-xARVCF 
(polyclonal) and anti-Myc (monoclonal) 
antibodies to detect xARVCF and RhoA, 
respectively. (a and c) Cells transfected 
with xARVCF and stained for xARVCF. 
(b and d) The same cells stained for the 
presence of RhoA (Myc epitope-tag). 
The dendritic phenotype is observed in 
xARVCF-transfected cells (a), while the 
reversal of this phenotype upon coexpres-
sion of V12-RhoA (DA-RhoA) is evident 
in panel c. 
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occurs too subtly to be detected in the assays used. This view
is supported by our observation that of the partial C-cad-
herin constructs tested, the EC produced the largest frac-
tional rescue of embryos depleted for xARVCF or Xp120.
Further, it is possible that C-cadherin’s intracellular signal-
ing (Rac activation?) capacity is reduced upon xARVCF or
Xp120 depletion as a simple consequence of lessened C-cad-
herin levels, perhaps accounting for the fractional capacity of
C-cadherin’s JMR domain to rescue Xp120 depletion. Inter-
estingly, because JMR mutants incapable of direct asso-
ciations with xARVCF or Xp120 continued to display
fractional rescuing activities, unknown JMR associations
are likely to play a significant role in C-cadherin’s cytoplas-
mic rescuing activity (Fedor-Chaiken et al., 2003; Ozawa,
2003). In any case, various laboratories will undoubtedly
continue to direct attention to the role of cadherin in acti-
vating or inhibiting Rho family members (outside-in signal-
ing; Kim et al., 2000; Nakagawa et al., 2001; Noren et al.,
2001; Goodwin et al., 2003) as well as the activity of Rho
family GTPases on cadherin function (inside-out signaling;
Wunnenberg-Stapleton et al., 1999; Braga, 2000; Fukata
and Kaibuchi, 2001; Ehrlich et al., 2002; Magie et al.,
2002). Our principal contribution here is in demonstrating
that ARVCF and p120 are required for vertebrate develop-
ment and that each catenin is closely functionally linked to
cadherin, RhoA, and Rac in vivo.
 
Materials and methods
 
MOs
 
MOs (25-mer) were obtained from Gene Tools, LLC and used in 
 
X. laevis
 
embryos in accordance with published procedures (Heasman et al., 2000).
The sequences of two 
 
X. laevis 
 
p120 morpholinos (Xp120-MO I and
Xp120-MO II) and of two 
 
X. laevis 
 
xARVCF morpholinos (xARVCF-MO I
and xARVCF-MO II) were as follows: Xp120-MO I, 5
 
 
 
-ACTCTGGCTCATC-
CATATAGAAAGG-3
 
 
 
; Xp120-MO II, 5
 
 
 
-AGAGACCCAAGTTCACACTC-
CAGGC-3
 
 
 
; xARVCF-MO I, 5
 
 
 
-CTGTTGGAGTTCGGCAGGCATCTAT-3
 
 
 
;
and xARVCF-MO II, 5
 
 
 
-ACACTGGCAGACCTGAGCCTATGGC-3
 
 
 
. A mor-
pholino standard (negative) control oligo was also obtained from Gene
Tools, LLC (5
 
 
 
-CCTCTTACCTCAGTTACAATTTATA-3 ). Morpholinos were
targeted against the following mRNA sequences relative to the translational
start site (ATG): Xp120-MO I ( 9 to  13), xARVCF-MO I ( 4 to  18),
Xp120-MO II ( 34 to  10), and xARVCF-MO II ( 75 to  50). GenBank
searches failed to detect significant complementarity of the Xp120 mor-
pholinos to xARVCF mRNA or of the xARVCF morpholinos to Xp120
mRNA. The morpholinos were resuspended in Nuclease-Free Water (Am-
bion) to the experimental concentrations required for microinjection.
X. laevis embryos and microinjection
X. laevis females were induced to lay eggs, which were fertilized and mi-
croinjected using published procedures (Montross et al., 2000). MOs and
mRNA constructs were microinjected into the animal hemisphere of one
or two blastomeres in 1-, 2-, or 4-cell cleavage stage embryos. The em-
bryos were placed within a solution of 5% ficoll in 1  MMR for culture at
18 C. The total volume of MOs and/or mRNA constructs injected was 20
nl, with the total doses of 20 or 40 ng for morpholinos, 0.02 ng for Xp120
or xARVCF mRNA, and 0.5 pg for RhoA or Rac mRNA. Embryonic pheno-
types were observed and evaluated using a standard binocular dissecting
microscope (model SMZ-U; Nikon).
RNA and in vitro transcription
The Xp120
ctn isoform 1 (Xp120 iso1) construct was PCR generated using
primers 5 -GAATTCGATGGATGAGCCAGAG-3  and 5 -GAATTCA-
CACGCTGATCTTC-3  and subcloned into pCS2 MT (Myc epitope tag) at
the EcoRI site (Kim et al., 2002). xARVCF isoform 1A (xARVCF-1A) con-
struct was PCR generated using primers 5 -GCTCTAGAATGATGCAG-
GAACC-3  and 5 -GCTCTAGACCCAAAAAGGGTCACTGC-3  and sub-
cloned into pCS2 HA (HA epitope tag) at the XbaI site (Kim et al., 2002).
RhoA and Rac (rat) constructs were a gift from M. Symons (North Shore
Long Island Jewish Research Institute, Bronx, NY). They were moved from
the original EXV vector by EcoRI digestion and subcloned into the EcoRI
site of pCS2 .
Capped mRNAs encoding these constructs were generated in vitro us-
ing the SP6 mMessage mMachine kit (Ambion) according to the manufac-
turer’s protocol. Unincorporated nucleotides were removed by filtration
through Sephadex G-50 Quick Spin Columns (Roche Applied Science).
The quantity and quality of transcribed mRNA products were evaluated on
the basis of migration within 1% agarose formaldehyde gels and by optical
density (OD 280/260).
Antibodies
Xp120 polyclonal antibodies were generated against the NH2- or COOH-
terminal domains of Xp120 (corresponding to amino acids 43–176 and
789–860). Each fragment was subcloned into the pQE32 vector having an
NH2-terminal 6   His tag (QIAexpress System; QIAGEN). The 6   His-
Xp120 fusion proteins were expressed and purified using Ni-NTA matrices
according to the manufacture’s instructions (QIAGEN) and raised at the in-
stitutional antibody core facility (University of Texas M.D. Anderson Can-
cer Center). The xARVCF polyclonal antibody was generated as described
previously (Paulson et al., 2000). The C-cadherin polyclonal antibody was
generated against the EC of X. laevis C-cadherin protein purified in the
same manner as Xp120 but was raised by Sigma-Genosys. Actin poly-
clonal antibody was purchased from Sigma-Aldrich.
Western blots
To evaluate endogenous or exogenous protein levels, embryos were har-
vested at the indicated developmental stages and lysates were prepared for
SDS-PAGE/Western blotting according to published procedures (1:5,000
dilution of antibodies directed against xARVCF, Xp120 NH2 terminus,
Xp120 COOH terminus, or C-cadherin; Kim et al., 2002).
Explant elongation assay
Morpholino oligos and/or mRNAs were injected at the 2-cell stage in the
animal pole region of both blastomeres. Animal caps were dissected from
injected embryos at stage 8 and incubated at 18 C overnight in 0.4  MMR
with or without human activin A (R&D Systems) at a final concentration of
20 ng/ml. Elongations of the isolated animal caps were evaluated using a
standard binocular dissecting microscope (model SMZ-U; Nikon).
Immunofluorescence of NIH-3T3 cells
Immunofluorescence localization procedures have been described previ-
ously (Anastasiadis et al., 2000). The primary antibodies used were di-
rected against xARVCF (polyclonal, 1:20,000) or Myc (9E10 monoclonal,
1  g/ml). Anti–murine-p120 mAb 12F4 was used in positive control assays
(1  g/ml). The secondary antibodies used were cross-absorbed goat anti–
mouse Alexa 488 (green; Molecular Probes) and goat anti–rabbit Alexa
596 (red; Molecular Probes; 1:600 dilutions). Coverslips were mounted on
glass slides using PolyMount (Polysciences, Inc.) and visualized under a
fluorescent microscope (model Optiphot 2; Nikon) with Plan Fluor (Nikon)
40  magnification (0.85 numerical aperture). Photos were acquired with
the Metamorph program using a CCD camera (model CoolSnap Fx; Photo-
metrics) and compiled in Photoshop and PowerPoint.
Image acquisition and manipulation
Image acquisition and manipulation procedures are described elsewhere
in Materials and methods in accordance with the indicated assays.
Online supplemental material
Eight supplemental figures and legends indicate the following: (a) cell–cell
interactions or tissue integrity is not graphically altered upon xARVCF or
Xp120 depletion (Figs. S1–S4); (b) C-cadherin deletion or point mutants
partially rescue Xp120 depletion (Fig. S5); (c) DA-Cdc42, DA-Rho, or DN-
Rac do not rescue xARVCF or Xp120 depletion (Fig. S6); (d) xARVCF coim-
munoprecipitates with Vav2 (Fig. S7); and (e) xARVCF and Xp120 coim-
munoprecipitate with DN-RhoA from X. laevis embryo extracts (Fig. S8).
Online supplemental material is available at http://www/jcb.org/cgi/
content/full/jcb.200307109/DC1.
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